These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 25070262)
41. In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4. Selvaraju RK; Velikyan I; Johansson L; Wu Z; Todorov I; Shively J; Kandeel F; Korsgren O; Eriksson O J Nucl Med; 2013 Aug; 54(8):1458-63. PubMed ID: 23761918 [TBL] [Abstract][Full Text] [Related]
42. Accuracy and reproducibility of absolute quantification of myocardial focal tracer uptake from molecularly targeted SPECT/CT: a canine validation. Liu YH; Sahul Z; Weyman CA; Dione DP; Dobrucki WL; Mekkaoui C; Brennan MP; Ryder WJ; Sinusas AJ J Nucl Med; 2011 Mar; 52(3):453-60. PubMed ID: 21321271 [TBL] [Abstract][Full Text] [Related]
43. A nanobody-based nuclear imaging tracer targeting dipeptidyl peptidase 6 to determine the mass of human beta cell grafts in mice. Demine S; Garcia Ribeiro R; Thevenet J; Marselli L; Marchetti P; Pattou F; Kerr-Conte J; Devoogdt N; Eizirik DL Diabetologia; 2020 Apr; 63(4):825-836. PubMed ID: 31873789 [TBL] [Abstract][Full Text] [Related]
44. Synthesis and preclinical evaluation of the CRTH2 antagonist [ Eriksson J; Roy T; Sawadjoon S; Bachmann K; Sköld C; Larhed M; Weis J; Selvaraju RK; Korsgren O; Eriksson O; Odell LR Nucl Med Biol; 2019 Apr; 71():1-10. PubMed ID: 31082767 [TBL] [Abstract][Full Text] [Related]
45. SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate. Müller C; Forrer F; Schibli R; Krenning EP; de Jong M J Nucl Med; 2008 Feb; 49(2):310-7. PubMed ID: 18199624 [TBL] [Abstract][Full Text] [Related]
46. [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting. Wild D; Béhé M; Wicki A; Storch D; Waser B; Gotthardt M; Keil B; Christofori G; Reubi JC; Mäcke HR J Nucl Med; 2006 Dec; 47(12):2025-33. PubMed ID: 17138746 [TBL] [Abstract][Full Text] [Related]
47. Noninvasive Evaluation of GPR119 Agonist Effects on β-Cell Mass in Diabetic Male Mice Using 111In-Exendin-4 SPECT/CT. Murakami T; Fujimoto H; Fujita N; Hamamatsu K; Matsumoto K; Inagaki N Endocrinology; 2019 Dec; 160(12):2959-2968. PubMed ID: 31613319 [TBL] [Abstract][Full Text] [Related]
48. Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models. Hellwig D; Menges M; Schneider G; Moellers MO; Romeike BF; Menger MD; Kirsch CM; Samnick S Nucl Med Biol; 2005 Feb; 32(2):137-45. PubMed ID: 15721759 [TBL] [Abstract][Full Text] [Related]
49. In vitro and in vivo characterization of three 68Ga- and 111In-labeled peptides for cholecystokinin receptor imaging. Roosenburg S; Laverman P; Joosten L; Eek A; Rutjes FP; van Delft FL; Boerman OC Mol Imaging; 2012; 11(5):401-7. PubMed ID: 22954184 [TBL] [Abstract][Full Text] [Related]
50. Imaging integrin αvβ3 on blood vessels with 111In-RGD2 in head and neck tumor xenografts. Terry SY; Abiraj K; Frielink C; van Dijk LK; Bussink J; Oyen WJ; Boerman OC J Nucl Med; 2014 Feb; 55(2):281-6. PubMed ID: 24408894 [TBL] [Abstract][Full Text] [Related]
51. Can DCE-MRI explain the heterogeneity in radiopeptide uptake imaged by SPECT in a pancreatic neuroendocrine tumor model? Bol K; Haeck JC; Groen HC; Niessen WJ; Bernsen MR; de Jong M; Veenland JF PLoS One; 2013; 8(10):e77076. PubMed ID: 24116203 [TBL] [Abstract][Full Text] [Related]
52. Preclinical properties and human in vivo assessment of 123I-ABC577 as a novel SPECT agent for imaging amyloid-β. Maya Y; Okumura Y; Kobayashi R; Onishi T; Shoyama Y; Barret O; Alagille D; Jennings D; Marek K; Seibyl J; Tamagnan G; Tanaka A; Shirakami Y Brain; 2016 Jan; 139(Pt 1):193-203. PubMed ID: 26490333 [TBL] [Abstract][Full Text] [Related]
53. Synthesis and evaluation of a radioiodinated peptide probe targeting αvβ6 integrin for the detection of pancreatic ductal adenocarcinoma. Ueda M; Fukushima T; Ogawa K; Kimura H; Ono M; Yamaguchi T; Ikehara Y; Saji H Biochem Biophys Res Commun; 2014 Mar; 445(3):661-6. PubMed ID: 24583127 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of 111In-labeled EPep and FibPep as tracers for fibrin SPECT imaging. Starmans LW; van Duijnhoven SM; Rossin R; Berben M; Aime S; Daemen MJ; Nicolay K; Grüll H Mol Pharm; 2013 Nov; 10(11):4309-21. PubMed ID: 24099178 [TBL] [Abstract][Full Text] [Related]
55. Low kidney uptake of GLP-1R-targeting, beta cell-specific PET tracer, Mikkola K; Yim CB; Lehtiniemi P; Kauhanen S; Tarkia M; Tolvanen T; Nuutila P; Solin O EJNMMI Res; 2016 Dec; 6(1):91. PubMed ID: 27957723 [TBL] [Abstract][Full Text] [Related]
56. SPECT imaging of fibrin using fibrin-binding peptides. Starmans LW; van Duijnhoven SM; Rossin R; Aime S; Daemen MJ; Nicolay K; Grüll H Contrast Media Mol Imaging; 2013; 8(3):229-37. PubMed ID: 23606426 [TBL] [Abstract][Full Text] [Related]
57. A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents. Gotthardt M; Lalyko G; van Eerd-Vismale J; Keil B; Schurrat T; Hower M; Laverman P; Behr TM; Boerman OC; Göke B; Béhé M Regul Pept; 2006 Dec; 137(3):162-7. PubMed ID: 16930741 [TBL] [Abstract][Full Text] [Related]
58. Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation. Greco A; Zannetti A; Pappatà S; Albanese S; Coda AR; Ragucci M; Nardelli A; Brunetti A; Cuocolo A; Salvatore M Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):112-117. PubMed ID: 26329495 [TBL] [Abstract][Full Text] [Related]